# K992697: Port-a-Cath II Trans-Arterial Percutaneous System

- Pathway: 510(k) (Traditional)
- Applicant: Sims Deltec, Inc.
- Decided: Nov 18, 1999 after 99 days
- Product code: LJT (Port & Catheter, Implanted, Subcutaneous, Intravascular)
- Device class: 2
- Regulation: 21 CFR 880.5965
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K830730 (1983). 2 ancestors in all.
3 later devices descend from it; 2 cite it directly.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K942024: Port-a-Cath Low Profile Implantable Venous Access System, Pharmacia Deltec, Inc. (1994) Summary page 2.
- K830730: Port-a-Cath Implantable Cath. Sys, Pharmacia, Inc. (1983) Summary page 2.

## Most influential descendants
- K061424: Celsite/ Celsite Concept, Access Ports (2006), 1 descendant of its own
- K130576: Celsite Implantable Access Port Systems (2013), 0 descendants of its own
- K033686: Port-a-Cath II Regional Arterial Portal System (2004), 0 descendants of its own

## Indications for use
A system is indicated when a patient requires prolonged or repeated intra-arterial infusion.

Source page: https://510kreport.com/device/K992697
Methodology: https://510kreport.com/methodology